6F2-73208-02214
3 vaccinations
8 coded responses
24 check-ins
8 free-text entries
5 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 852 / AZ
- Registered
- 2021-01-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-27
Dose 1 — Pfizer-BioNTech
-
2021-01-17
Dose 2 — Pfizer-BioNTech
-
2021-01-19
Registered in v-safe
-
2021-01-19
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-01-22
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-01-23
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Joint pains, Muscle or body achesAdult check-in
-
2021-01-24
Survey response — day 7, dose 2MedDRA: Adverse reaction — Feeling: Good · Site: Pain · Joint pains, Muscle or body achesFree text: I couldnt report the first three days because this system did not work-those symptoms were substantial and itd be great to be able to provide that data!MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-31
-
2021-02-09
Survey response — day 21, dose 2MedDRA: Hypersensitivity — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Multiple allergic reactions. Not vaccine related.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-09
Report sent to call center — day 21, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-02-14
- 2021-02-21
- 2021-03-02
-
2021-04-18
Survey response — 3 months, dose 2MedDRA: Hypersensitivity, Respiratory symptom — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Allergies / upper respiratory symptomsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-16
-
2021-07-18
Survey response — 6 months, dose 2MedDRA: Pneumonia, Upper respiratory tract infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Upper respiratory infection/ pneumoniaMedDRA releases: 2024-11 · check-in free text available
-
2021-07-18
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-07-22
-
2021-10-14
Dose 3 — Pfizer-BioNTech
-
2021-10-15
Survey response — days 1–6 daily, dose 3MedDRA: Tachycardia — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: TachycardiaMedDRA releases: 2024-11 · check-in free text available
-
2021-10-16
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-10-17
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-10-20
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-10-21
Health check-in — day 7, dose 3Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-10-30
- 2021-11-04
- 2021-11-11
- 2021-11-18
- 2021-11-25
-
2022-01-13
Survey response — 3 months, dose 3MedDRA: COVID-19, SARS-CoV-2 test positive — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: COVID 19 infection PCR positiveMedDRA releases: 2024-11 · check-in free text available
-
2022-01-13
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-01-14
- 2022-01-19
-
2022-04-16
Survey response — 6 months, dose 3MedDRA: COVID-19, Pre-existing disease — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: On going chronic issues and a covid 19 infectionMedDRA releases: 2024-11 · check-in free text available
-
2022-04-16
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-04-19
- 2022-04-22
-
2022-10-14
Survey response — 12 months, dose 3MedDRA: Postural orthostatic tachycardia syndrome, Unevaluable event — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Symptoms: Diagnosed with POTS. Not covid related · Healthcare visit (other): TestingMedDRA releases: 2024-11 · check-in free text available
-
2022-10-14
Report sent to call center — 12 months, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-10-17
- 2022-10-17
- 2022-10-17
- 2022-10-17
- 2022-10-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-27 | Pfizer-BioNTech | |
| 2 | 2021-01-17 | Pfizer-BioNTech | |
| 3 | 2021-10-14 | Pfizer-BioNTech | No |
Call center
5 call center cases
5 unsuccessful
2 waits over 3 months for a first call
Free text
Release 2 — day 7, dose 2
Systemic reaction (other): I couldnt report the first three days because this system did not work-those symptoms were substantial and itd be great to be able to provide that data!
Release 3 — day 21, dose 2
Symptoms: Multiple allergic reactions. Not vaccine related.
Release 7 — 3 months, dose 2
Symptoms: Allergies / upper respiratory symptoms
Release 9 — 6 months, dose 2
Symptoms: Upper respiratory infection/ pneumonia
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Tachycardia
Release 10 — 3 months, dose 3
Symptoms: COVID 19 infection PCR positive
Release 11 — 6 months, dose 3
Symptoms: On going chronic issues and a covid 19 infection
Release 12 — 12 months, dose 3
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Hypersensitivity | ✓ | ✓ | ✓ |
| SD | Pneumonia | · | · | ✓ |
| SD | Postural orthostatic tachycardia syndrome | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Respiratory symptom | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
| SRO | Adverse reaction | ✓ | ✓ | ✓ |
| SRO | Tachycardia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release